Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Buckwheat honey is a dark, monofloral honey produced by honey bees (*Apis mellifera*) from the nectar of buckwheat (*Fagopyrum esculentum*) flowers. It is distinguished from other honey varieties by its high mineral content, robust antioxidant capacity, and a unique profile of phenolic acids, including gallic, p-hydroxybenzoic, and p-coumaric acids. The honey contains significant levels of rutin, 4-hydroxybenzoic acid, and various melanoidin precursors that function as transition metal chelators. Clinically, buckwheat honey has been investigated as a natural antitussive for the management of acute cough associated with upper respiratory tract infections (URTI), where it acts as a demulcent to soothe the pharyngeal mucosa and exhibits antimicrobial properties against pathogens such as *Bacillus subtilis* and *Pseudomonas aeruginosa*. Its high antioxidant activity, often compared favorably to Manuka honey, is attributed to its rich concentration of polyphenols and organic acids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on buckwheat honey.